A New Treatment for Dry Eye Syndrome Will Soon be Available

I have mentioned to many of our dry eye patients that a cream with testosterone was being researched and would give us another avenue of relief for our patients.  Argentis has licensed a testosterone-progesterone therapy for dry eye syndrome.  Argentis is licensing this compound from the Southern College of Optometry. I expect this compound to be very helpful for patients with dry eyes and look forward to prescribing it for our patients.  It is not available for us to prescribe yet, however we will update this entry as soon as it is.

Comments are closed.